Microbiome Report for Week Ending 3/9/19

Microbiome Report for Week Ending 3/9/19

Source: 
CP Wire
snippet: 


Synlogic, Inc (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced on 3/6/19 the advancement of Synthetic Biotic medicines to the lead optimization stage in its collaboration with AbbVie, a global biopharmaceutical company, to develop an oral treatment for inflammatory bowel disease (IBD).